JPC
BIIB icon

Jackson Park Capital’s Biogen BIIB Stock Holding History

Jackson Park Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.47M Sell
8,700
-3,000
-26% -$889K 4.59% 7
2016
Q3 		$3.66M Hold
11,700
– – 4.75% 2
2016
Q2 		$2.83M Buy
+11,700
New +$3.08M 3.88% 10

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jackson Park Capital's BIIB Position: Q4 2016 in Review

Jackson Park Capital reduced its Biogen (BIIB) stake by 26% in Q4 2016, selling an estimated $889K and leaving 8,700 shares worth $2.47M. The position accounts for 4.59% of the portfolio, ranked #7.

Jackson Park Capital first reported a position in BIIB in Q2 2016 and has held it in 3 quarters since. The position peaked at $3.66M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Jackson Park Capital held 8,700 shares of Biogen worth $2.47M as of Q4 2016.
  • Jackson Park Capital sold 3,000 Biogen shares in Q4 2016, an estimated $889K.
  • Biogen made up 4.59% of Jackson Park Capital's portfolio in Q4 2016, its #7 holding.
  • Jackson Park Capital first reported a position in Biogen in Q2 2016 and has held it in 3 quarters since.
  • Jackson Park Capital's Biogen position peaked at $3.66M in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Jackson Park Capital's 13F filing for Q4 2016, filed 1 Feb 2017.